Celltrion Inc
General
Total Cases51
Active Cases3
Patents26
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
L5
D
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/16/24 | ORDER of USCA for the Federal Circuit as to 259 Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., 258 Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) | |
| 09/13/24 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # [1] Exhibit Ex. A, # [2] Exhibit Ex. B, # [3] Exhibit Ex. C, # [4] Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) | |
| 09/03/24 | ORDER GRANTING MOTIONS TO WITHDRAW. For good cause, they are GRANTED (ECF Nos. 323 , 324 ). Renee M. Griffin and Yi Zhang shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/03/2024) | |
| 08/30/24 | MOTION to Withdraw as Attorney YI ZHANG'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) | |
| 08/30/24 | MOTION to Withdraw as Attorney RENEE M. GRIFFIN'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) | |
| 08/02/24 | NOTICE by Regeneron Pharmaceuticals, Inc. of Judgments from the Patent and Trademark Office (Attachments: # [1] Attachment July 23, 2024 Order ('572 patent), # [2] Attachment July 30, 2024 Judgment ('601 patent))Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/02/2024) | |
| 07/31/24 | USCA FOR THE FEDERAL CIRCUIT NOTICE OF APPELLATE CASE OPENING: re 269 in 1:24-md-03103-TSK-JPM and [204] in 1:23-cv-00089-TSK-JPM. Notice of Appeal filed by Celltrion, Inc. Federal Circuit USCA Case Number: 2024-2147. (snc) (Entered: 07/31/2024) | |
| 07/29/24 | ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 293 ). Signed by Chief District Judge Thomas S. Kleeh on 07/29/2024. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM (snc) (Entered: 07/29/2024) | |
| 07/26/24 | MOTION for Leave to File UNDER SEAL by Regeneron Pharmaceuticals, Inc.. (Attachments: # 1 Attachment Memorandum in Support, # 2 Proposed Order)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00089-TSK-JPM(Ruby, Steven) (Entered: 07/26/2024) | |
| 07/23/24 | The following patents were found to be Patentable by PTAB:
Patent US11253572 in IPR2024-00260 |